Paloma Partners Management CO Invitae Corp Transaction History

Paloma Partners Management CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.13 - $9.01 $57,912 - $244,972	-27,189 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$6.28 - $15.59 $170,746 - $423,876	27,189 New	27,189 $217,000
Q1 2021 May 17, 2021	SELL	$33.06 - $56.93 $1.09 Million - $1.87 Million	-32,929 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$39.09 - $57.4 $1.29 Million - $1.89 Million	32,929 New	32,929 $1.38 Million
Q1 2020 May 15, 2020	SELL	$7.64 - $27.5 $280,472 - $1.01 Million	-36,711 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$15.02 - $20.57 $268,933 - $368,305	-17,905 Reduced 32.78%	36,711 $593,000
Q3 2019 Nov 14, 2019	BUY	$18.85 - $27.5 $1.03 Million - $1.5 Million	54,616 New	54,616 $1.05 Million

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

Stay updated on Paloma Partners Management CO with notifications on news.